James P. Scanlan, Attorney at Law

Home Page

Curriculum Vitae

Publications

Published Articles

Conference Presentations

Working Papers

Journal Comments

Truth in Justice Articles

Measuring Health Disp

Outline and Guide to MHD

Summary to MHD

Solutions

Solutions Database

Irreducible Minimums

Pay for Performance

Between Group Variance

Concentration Index

Gini Coefficient

Reporting Heterogeneity

Cohort Considerations

Relative v Absolute Diff

NHDR Technical Issues

MHD A Articles

MHD B Conf Presentations

MHD D Journal Comments

Consensus/Non-Consensus

Institutional Corresp

Scanlan's Rule

Outline and Guide to SR

Summary to SR

Semantic Issues

Employment Tests

Case Study

Case Study Answers

Subgroup Effects

Illogical Premises

Illogical Premises II

Inevitable Interaction

Feminization of Poverty

Explanatory Theories

Mortality and Survival

Immunization Disparities

Truncation Issues

Income Illustrations

Framingham Illustrations

Life Table Illustrations

NHANES Illustrations

Representational Disp

Statistical Signif SR

Comparing Averages

Meta-Analysis

Case Control Studies

Mortality and Survival 2

Measures of Association

Educational Disparities

Nuclear Deterrence

Employment Discrimination

Job Segregation

Measuring Hiring Discr

Lending Disparities

Disparities - High Income

Adjustment Issues - LD

Affirmative Action

Affirm Action for Women

Other Affirm Action

Justice John Paul Stevens

Statistical Reasoning

The Sears Case

The AT&T Consent Decree

Cross v. ASPI

Vignettes

Times Higher Issues

Gender Diff in DADT Term

Adjustment Issues

Percentage Points

Odds Ratios

Statistical Signif Vig

Journalists & Statistics

Prosecutorial Misconduct

Outline and Guide

Misconduct Summary

B1 Agent Cain Testimony

B1a Bev Wilsh Diversion

B2 Bk Entry re Cain Call

B3 John Mitchell Count

B3a Obscuring Msg Slips

B3b Missing Barksdale Int

B4 Park Towers

B5 Dean 1997 Motion

B6 Demery Testimony

B7 Sankin Receipts

B7a Sankin HBS App

B8 DOJ Complicity

B9 Doc Manager Complaints

B9a Fabricated Gov Exh 25

B11a DC Bar Complaint

Letters (Misconduct)

Links Page

Misconduct Profiles

Arlin M. Adams

Jo Ann Harris

Bruce C. Swartz

Swartz Addendum 2

Swartz Addendum 3

Swartz Addendum 4

Swartz Addendum 7

Robert E. O'Neill

O'Neill Addendum 7

Paula A. Sweeney

Robert J. Meyer

Lantos Hearings

Password Protected

OIC Doc Manager Material

DC Bar Materials

Temp Confidential

DV Issues

Document Storage

Pre 1989

1989 - present

Presentations

Prosec Misc Docs

Prosec Misc Docs II

Profile PDFs

Misc Letters July 2008 on

Large Prosec Misc Docs

HUD Documents

Transcripts

Miscellaneous Documents

Unpublished Papers

Letters re MHD

Tables

MHD Comments

Figures

ASPI Documents

Web Page PDFs

Pages Transfer


CONCENTRATION INDEX

(Dec. 9, 2009; rev. Jan. 2, 2010)

 

The Concentration Index is an increasingly popular measure of health disparities, as are certain other summary measures of disparities, such as the Relative Index of Inequality.  These measures purport to take into account both the sizes of disparities between particular population groups and the proportion each group makes up of the total population.

 

Even if these summary measures were based on sound approaches to appraising differences between individual groups, there are issues as to whether they effectively take into account the size of the groups being compared.  For they are in significant part functions of the sizes of differences (however measured) between groups at the extremes, and those differences will typically be affected by the proportion each group makes up of the total population.  That is, a difference between the top and bottom 10 percent of the population will generally be greater than the difference between the top and bottom 20 percent of the populations.  There is also a question whether it is useful to confound issues concerning the size of disparities between groups with issues concerning the sizes of the groups. 

 

The subject of this item, however, concerns the way that the concentration index is a flawed measured of health disparities because it is a function of relative differences between rates and hence subject to the same factors that undermine relative differences as effective measures of differences in the well-being of two groups – specifically, that relative differences tend to be affected by the overall prevalence of an outcome, or, more specifically, that the rarer an outcome, the greater tends to be the relative difference in experiencing it and the smaller tends to be the relative difference in avoiding – as discussed the Measuring Health Disparities page (MHD) and Scanlan’s Rule page (SR) of this site and the hundred or so references that those pages make available.

 

A crucial requirement of any measure of health disparities is that it is unaffected by the overall prevalence of an outcome – that is, that it remains the same when there occurs a simple change in overall prevalence akin to that effected by the lowering a cutoff on a test.  The concentration index  does not satisfy that requirement. 

 

Table A below replicates five key columns of Table 1 of the 2006 British Society for Population Studies presentation.  That table, which can be accessed in its entirety by the indicated link, showed the implications as to various measures of differences between failure rates or pass rates of the lowering of a cutoff on a test where two groups with normal distributions have mean scores that differ by half a standard deviation, and it underlies many graphic illustrations of those implications.  The final two columns added to the abbreviated version of the table below show the concentration index scores both for failing and for passing the test at each cutoff where each group comprises one half of the population. 

 

 

Table A – Data from Table 1 of BSPS 2006

with Concentration Indexes Added

Cut Point

(1)AG Fail%

(2)DG Fail%

(3)Rat DGF%/ AGFail%

(6)Rat AGP%/ DGP

Failure CI

Passage

CI

A 99

99.00

99.76

1.01

4.24

-0.0019

-0.3065

B 97

97.00

99.13

1.02

3.47

-0.0054

-0.2760

C 95

95.00

98.38

1.04

3.12

-0.0087

-0.2555

D 90

90.00

96.25

1.07

2.67

-0.0168

-0.2271

E 80

80.00

90.99

1.14

2.22

-0.0321

-0.1894

F 70

70.00

84.61

1.21

1.96

-0.0473

-0.1610

G 60

60.00

77.34

1.29

1.77

-0.0631

-0.1383

H 50

50.00

69.15

1.38

1.62

-0.0804

-0.1184

I 40

40.00

59.48

1.48

1.48

-0.0979        

-0.0969

J 30

30.00

49.20

1.63

1.37

-0.1212

-0.0795

K 20

20.00

36.69

1.83

1.26

-0.1472

-0.0582

L 10

10.00

21.77

2.17

1.15

-0.1852

-0.0350

M 5

5.00

12.71

2.52

1.09

-0.2177

-0.0212

N 3

3.00

8.38

2.79

1.06

-0.2364

-0.0143

O 1

1.00

3.44

3.38

1.03

-0.2747

-0.0062

 

It will be noted that, as with the relative differences in failing and passing a test, the concentration indexes for the two outcomes change in opposite directions as a cutoff is lowered and the adverse outcome becomes less common and the favorable outcome becomes more common.  The key point, however, is that the concentration index change at all simply when there occurs a change in overall prevalence.  Such fact demonstrates that the concentration index cannot identify changes in inequalities that are other than the statistically-driven consequences of changes in overall prevalence.

 

The formula for calculating the concentration index is that discussed on page 67 of the National Cancer Institute document Methods for Measuring Cancer Disparities Using Data Relevant to Health People 2010 Cancer-Related Objectives (by Sam Harper and John Lynch).  Table B below replicates the document’s methodology with regard to changes in educational differences in mammography rates between 1900 and 2002, the document calculated for its Table A1 (at 68) in terms of rates of failure to receive mammography (in accordance with the recommendation of the National Center for Health Statistics recommendation that all disparities be measured in terms of relative differences in adverse outcomes, which recommendation I criticize in a number of places, including Section E.4 of MHD and Section A .6 of SR).  This occurred during a period of substantial increases in mammography rates.

 

Table B below compares in concentration index for failure to receive mammography with the concentration index for receipt of mammography.

 

Table B – Concentration Indexes for Failure to Receive Mammography and Receipt of Mammography by Education Group

Year

NoMammographyCI

MammographyCI

1990

-0.1025

-0.7148

2002

-0.0998

-0.3328

 

It will be observed that the concentration index for absence of a mammography decreased very slightly while the concentration index for receipt of mammography decreased substantially.  A decrease in  the relative difference in an adverse outcome (or even the absence of an increase) when an adverse outcome is declining would tend to signal a meaningful decrease in the disparity.  And when the relative difference in a declining outcome decreases somewhat, the relative difference in the opposite outcome will tend to decrease substantially.  Of course, as indicated at the outset, as the matter is influenced by changes in the size of the groups being compared, it is difficult to interpret these patterns.

 

Table C shows that, according to the approach described on the Solutions sub-page or MHD, the disparity between the lowest and highest education group decreased a fair amount, which accords with the pattern also shown whereby the relative difference in the adverse outcomes and the favorable outcomes both decreased.   This illustration, however, is a digression from the subject of this item, which involves the reason that the concentration index is a fundamentally flawed measure of health disparities.

 

Table C – Non-receipt and Receipt Ratios and Estimate Effect Size for  Differences in Mammography between Lowest and Highest Education Groups , 1990 and 2002

Year

E8

E16

No Mammo Ratio

Mammo Ratio

EES

1990

54.20%

29.00%

1.88

1.55

0.68

2002

33.30%

18.60%

1.79

1.22

0.46

 

Finally, it warrants note that there is also an absolute concentration index.  Inasmuch as absolute differences are the same regardless of whether one examines the favorable or the adverse outcome, the absolute concentration index presumably would be unaffected by which rate one examines.  But, as with the absolute difference itself, the measure remains problematic as a measure of health disparities because it is affected by the overall prevalence of an outcome.[i]



[i]   See Table 1 of the Comment on Bostrom regarding the way the Gini Coefficient is affected by the overall prevalence of an outcome.